drugset / Trial / NCT04258826
A Study to Evaluate LY3154207 on the Brain of Healthy Participants
RandomizedCrossoverDouble-blindBasic science
Summary
The purpose of this study is to learn more about how LY3154207 affects the brain of healthy participants by using magnetic resonance imaging. The study will last up to about nine weeks for each participant and may include up to four visits to the study center.
Timeline
- Start
- 2021-01-15
- Primary completion
- 2022-01-28
- Completion
- 2022-01-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mevidalen | Small molecule | — | Oral |
Indications
No indication recorded.